• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纽约曼哈顿川崎病患者的冠状动脉受累情况:危险因素及阿司匹林的作用

Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin.

作者信息

Ichida F, Fatica N S, Engle M A, O'Loughlin J E, Klein A A, Snyder M S, Ehlers K H, Levin A R

机构信息

Division of Pediatric Cardiology, New York Hospital-Cornell Medical Center, NY 10021.

出版信息

Pediatrics. 1987 Dec;80(6):828-35.

PMID:3684392
Abstract

Since January 1980, 110 children having 113 attacks of Kawasaki syndrome were studied. Age at onset was 7 weeks to 12 years (mean 3 6/12 years, median 2 9/12 years); 77% were younger than 5 years of age; the male to female ratio was 1.8; racial distribution was 52% white, 19% black, 14% Hispanic, and 16% Asian. Protocol of management consisted of high-dose aspirin (100 mg/kg/d) until afebrile, and then 81 mg every day until free of coronary aneurysm. Two-dimensional echocardiograms were done weekly during the acute stage, at 2 and 6 months after onset, and yearly if a coronary abnormality was detected. At 1 month, 51 coronary arterial abnormalities were present in 25 patients. Risk factors for a coronary abnormality were duration of fever greater than or equal to 2 weeks, level of platelet count, marked elevation of ESR, and age younger than 5 years. No statistically significant difference in incidence of aneurysms was detected between patients on high-dose aspirin and those on medium-or low-dose aspirin.

摘要

自1980年1月起,对110名患有113次川崎综合征发作的儿童进行了研究。发病年龄为7周龄至12岁(平均3.5岁,中位数2.75岁);77%的患儿年龄小于5岁;男女比例为1.8;种族分布为52%白人、19%黑人、14%西班牙裔和16%亚裔。治疗方案包括在发热消退前给予大剂量阿司匹林(100mg/kg/天),然后每天给予81mg,直至无冠状动脉瘤。在急性期每周进行二维超声心动图检查,发病后2个月和6个月进行检查,如果检测到冠状动脉异常则每年检查一次。在1个月时,25名患者出现51处冠状动脉异常。冠状动脉异常的危险因素包括发热持续时间大于或等于2周、血小板计数水平、血沉显著升高以及年龄小于5岁。在接受大剂量阿司匹林治疗的患者与接受中剂量或低剂量阿司匹林治疗的患者之间,未检测到动脉瘤发生率的统计学显著差异。

相似文献

1
Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin.纽约曼哈顿川崎病患者的冠状动脉受累情况:危险因素及阿司匹林的作用
Pediatrics. 1987 Dec;80(6):828-35.
2
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.急性川崎病的治疗:重新审视阿司匹林在发热阶段的作用。
Pediatrics. 2004 Dec;114(6):e689-93. doi: 10.1542/peds.2004-1037. Epub 2004 Nov 15.
3
Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children.初始皮质类固醇治疗对川崎病冠状动脉瘤形成的影响:对862名儿童的荟萃分析
Pediatrics. 2005 Oct;116(4):989-95. doi: 10.1542/peds.2005-0504.
4
[Kawasaki disease: clinical characteristics and cardiovascular involvement in a cohort of 121 patients].[川崎病:121例患者队列的临床特征及心血管受累情况]
Pediatr Med Chir. 2002 Sep-Oct;24(5):352-7; discussion 397-9.
5
[Cardiovascular complications of Kawasaki disease: clinical cases].[川崎病的心血管并发症:临床病例]
Pediatr Med Chir. 1995 Nov-Dec;17(6):531-3.
6
[Kawasaki syndrome].[川崎病]
Schweiz Med Wochenschr. 1990 Apr 14;120(15):539-47.
7
[Kawasaki disease: heart disease during childhood].[川崎病:儿童期心脏病]
Rev Esp Cardiol. 2006 Apr;59(4):387-90.
8
New hope for children with Kawasaki disease.川崎病患儿的新希望。
J Pediatr Nurs. 1991 Jun;6(3):159-65.
9
Early treatment with intravenous immunoglobulin in patients with Kawasaki disease.川崎病患者早期静脉注射免疫球蛋白治疗。
J Pediatr. 2002 Apr;140(4):450-5. doi: 10.1067/mpd.2002.122469.
10
Prediction of patients with a high risk of coronary artery aneurysm in Kawasaki disease: indication for immunoglobulin therapy.川崎病冠状动脉瘤高危患者的预测:免疫球蛋白治疗的指征
Prog Clin Biol Res. 1987;250:287-97.

引用本文的文献

1
Two Distinct Cases of Adult-onset Kawasaki Disease.两例成人发病川崎病。
Intern Med. 2022 Dec 1;61(23):3525-3529. doi: 10.2169/internalmedicine.9044-21. Epub 2022 Apr 23.
2
Treatment of Kawasaki Disease: A Network Meta-Analysis of Four Dosage Regimens of Aspirin Combined With Recommended Intravenous Immunoglobulin.川崎病的治疗:阿司匹林四种剂量方案联合推荐静脉注射免疫球蛋白的网状Meta分析
Front Pharmacol. 2021 Aug 12;12:725126. doi: 10.3389/fphar.2021.725126. eCollection 2021.
3
Comparison of Risk of Recrudescent Fever in Children With Kawasaki Disease Treated With Intravenous Immunoglobulin and Low-Dose vs High-Dose Aspirin.
比较静脉注射免疫球蛋白和低剂量与高剂量阿司匹林治疗川崎病儿童复发性发热的风险。
JAMA Netw Open. 2020 Jan 3;3(1):e1918565. doi: 10.1001/jamanetworkopen.2019.18565.
4
Risk Factors of Coronary Artery Abnormality in Children With Kawasaki Disease: A Systematic Review and Meta-Analysis.川崎病患儿冠状动脉异常的危险因素:系统评价与Meta分析
Front Pediatr. 2019 Sep 26;7:374. doi: 10.3389/fped.2019.00374. eCollection 2019.
5
Kawasaki Disease and Labyrinthitis: An Underdiagnosed Complication.川崎病与迷路炎:一种未被充分诊断的并发症。
J Audiol Otol. 2017 Apr;21(1):53-56. doi: 10.7874/jao.2017.21.1.53. Epub 2017 Mar 30.
6
Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment.对初次治疗难治性川崎病患者第二次静脉注射免疫球蛋白治疗无反应的预测
Korean J Pediatr. 2016 Oct;59(10):408-413. doi: 10.3345/kjp.2016.59.10.408. Epub 2016 Oct 17.
7
Critical Overview of the Risk Scoring Systems to Predict Non-Responsiveness to Intravenous Immunoglobulin in Kawasaki Syndrome.川崎病静脉注射免疫球蛋白无反应风险评分系统的评价综述。
Int J Mol Sci. 2016 Feb 24;17(3):278. doi: 10.3390/ijms17030278.
8
Can Coronary Artery Involvement in Kawasaki Disease be Predicted?川崎病冠状动脉受累能否预测?
Diagnostics (Basel). 2013 Mar 26;3(2):232-43. doi: 10.3390/diagnostics3020232.
9
Epidemiology and management of Kawasaki disease.川崎病的流行病学和管理。
Drugs. 2012 May 28;72(8):1029-38. doi: 10.2165/11631440-000000000-00000.
10
Diagnosis of incomplete Kawasaki disease.不完全川崎病的诊断。
Korean J Pediatr. 2012 Mar;55(3):83-7. doi: 10.3345/kjp.2012.55.3.83. Epub 2012 Mar 16.